First Trust Capital Strength ETF (FTCS)
Investment Objective/Strategy - The First Trust Capital Strength ETF seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called The Capital Strength IndexSM.
There can be no assurance that the Fund's investment objectives will be achieved.
Index Description According to the Index Provider
  • A security must be a common stock or REIT that is a member of the NASDAQ US Benchmark Index. The largest 500 securities by float-adjusted market capitalization with a minimum three-month average daily dollar trading volume of $5 million are selected. Multiple share classes of the same issuer are excluded.
  • To be eligible for inclusion in the Index, companies must have:
    • at least $1 billion in cash or short term investments.
    • a long term debt to market cap ratio less than 30%.
    • a return on equity greater than 15%.
  • Eligible companies are then ranked by a combined short-term (3 months) and long-term (12 months) realized volatility.
  • The 50 companies with the lowest combined volatility score are selected for inclusion in the Index.
  • A maximum weight of 30% in any one Industry Classification Benchmark industry is allowed. If an industry has a weight greater than 30%, the highest ranking security by volatility will be removed and replaced with the next eligible security from a different industry. This process is repeated until no industry has a weight greater than 30%.
  • The Index stocks are equally weighted initially and on each rebalancing effective date. The index is reconstituted and rebalanced on a quarterly basis.
Fund Overview
TickerFTCS
Fund TypeLarge Cap Core
Investment AdvisorFirst Trust Advisors L.P.
Investor Servicing AgentBank of New York Mellon Corp
CUSIP33733E104
ISINUS33733E1047
Intraday NAVFTCSIV
Fiscal Year-End12/31
ExchangeNasdaq
Inception7/6/2006
Inception Price$20.00
Inception NAV$20.00
Rebalance FrequencyQuarterly
Gross Expense Ratio*0.55%
Net Expense Ratio*0.55%
* As of 5/2/2022
Expenses are capped contractually at 0.65% per year, at least through April 30, 2023.
Current Fund Data (as of 9/30/2022)
Closing NAV1$66.28
Closing Market Price2$66.42
Bid/Ask Midpoint$66.32
Bid/Ask Premium0.05%
30-Day Median Bid/Ask Spread30.04%
Total Net Assets$7,439,574,217
Outstanding Shares112,250,002
Daily Volume582,030
Average 30-Day Daily Volume362,571
Closing Market Price 52-Week High/Low$84.75 / $66.42
Closing NAV 52-Week High/Low$84.72 / $66.28
Number of Holdings (excluding cash)50
Top Holdings (as of 9/30/2022)*
Holding Percent
Regeneron Pharmaceuticals, Inc. 2.40%
Trane Technologies Plc 2.36%
Nasdaq, Inc. 2.29%
Automatic Data Processing, Inc. 2.23%
Cummins Inc. 2.19%
Air Products and Chemicals, Inc. 2.18%
W.R. Berkley Corporation 2.16%
Northrop Grumman Corporation 2.15%
Amphenol Corporation 2.14%
Danaher Corporation 2.13%

* Excluding cash.  Holdings are subject to change.

NAV History (Since Inception)
Past performance is not indicative of future results.
Overall Morningstar RatingTM (as of 8/31/2022)4

Among 1,231 funds in the Large Blend category. This fund was rated 2 stars/1,231 funds (3 years), 3 stars/1,111 funds (5 years), 5 stars/818 funds (10 years) based on risk adjusted returns.
Distribution Information
Dividend per Share Amt (as of 10/3/2022)5$0.2563
30-Day SEC Yield (as of 8/31/2022)61.39%
Unsubsidized 30-Day SEC Yield (as of 8/31/2022)71.39%
12-Month Distribution Rate (as of 8/31/2022)81.15%
Index Yield (as of 8/31/2022)92.03%
Fund Characteristics (as of 8/31/2022)11
Maximum Market Cap.$485,772
Median Market Cap.$69,314
Minimum Market Cap.$15,436
Price/Earnings19.85
Price/Book4.99
Price/Cash Flow15.44
Price/Sales1.86
Bid/Ask Premium/Discount (as of 9/30/2022)
  2021 Q1 2022 Q2 2022 Q3 2022
Days Traded at Premium 186 37 42 46
Days Traded at Discount 66 25 20 18
Top Sector Exposure (as of 9/30/2022)
Industrials 30.92%
Health Care 29.71%
Financials 13.90%
Consumer Staples 11.58%
Technology 4.19%
Consumer Discretionary 3.83%
Basic Materials 2.18%
Telecommunications 1.96%